Hydroxyzine Orion

Hydroxyzine Hydrochloride, the active ingredient in Hydroxyzine Orion, is an antihistamine presented as an oral dosage form for oral use. It is employed to relieve symptoms of allergic rhinitis, pruritus, anxiety and to provide sedation before surgical procedures. GNH USA supplies Hydroxyzine Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydroxyzine Orion is an antihistamine that acts on peripheral H1 receptors to control allergic and related conditions. - Allergic rhinitis: reduces nasal itching, sneezing and rhinorrhea. - Pruritus: alleviates skin itching associated with allergic dermatoses. - Anxiety: provides short‑term relief of tension and nervousness. - Pre‑operative sedation: produces calming effect before surgery.

Hydroxyzine Orion may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling of sleepiness or reduced alertness. - Dry mouth: decreased salivation leading to a parched sensation. - Dizziness: light‑headed feeling, especially when standing quickly. - Blurred vision: temporary difficulty focusing.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm that may require medical attention. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hemolytic anemia: destruction of red blood cells leading to fatigue and pallor.

Before prescribing Hydroxyzine Orion, clinicians should consider several safety factors. - Pregnancy: consult a physician as safety data are limited. - Elderly patients: monitor for heightened sedation and falls. - Renal impairment: dose adjustment may be necessary. - Concomitant CNS depressants: may amplify sedative effects. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Hydroxyzine Orion can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Alcohol: additive central nervous system depression. - Opioids: increased sedation and risk of respiratory depression. - Anticholinergic agents: heightened anticholinergic side effects.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may raise hydroxyzine plasma concentrations. - Other CNS depressants (e.g., benzodiazepines): may enhance drowsiness.